The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced that they will hold several closed meetings this February to review and evaluate contract proposals for developing pediatric formulations of tuberculosis drugs. These meetings are held under the Federal Advisory Committee Act and are closed to the public to protect confidential information and personal privacy. The meetings will be virtual, and they are occurring on February 22 and February 24, 2021, with participation led by Scientific Review Officer Mario Cerritelli. The announcements are being made less than 15 days before the meetings due to scheduling requirements aligned with the review and funding process.
Simple Explanation
The National Institute of Allergy and Infectious Diseases is having secret meetings on how to make better medicine for kids with a lung disease, but they're not telling anyone because they want to keep it private. They didn't tell people about the meetings until it was almost time for them to happen.